During the past decade, State Healthcare Institution "Regional Clinical Cardiology Dispensary" conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" #1 collaborator was "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" are "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Resistant Hypertension" (1 trials). Many other conditions were trialed in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" in a lesser frequency.

Most popular intervention types in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials) and "Macitentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" are 2 trials for "All" genders.

Currently, there are NaN active trials in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in State Healthcare Institution "Regional Clinical Cardiology Dispensary", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in State Healthcare Institution "Regional Clinical Cardiology Dispensary", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".